Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
This study has been completed.
Study NCT00282048   Information provided by Pfizer
First Received: January 23, 2006   Last Updated: November 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Neoplasms
Carcinoma, Renal Cell
Additional conditions recognized in this trial
Carcinoma
Neoplasms
More general conditions related to this trial
Adenocarcinoma
Kidney Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
AG-013736 (axitinib)
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services